Biotechnology Epidemiology Immunotherapies Infection Control Infectious Diseases rare diseases New antigen test for detecting COVID-19 could help triage patients during the pandemic By Staff Reports 5 months ago COVID-19 Ag Respi-Strip test can identify an infected person in 15 minutes at point-of-care sites
Biotechnology Diabetes Uncategorized Smart Contact Lenses that Diagnose and Treat Diabetes By Staff Reports 5 months ago Diabetes is called an incurable disease because once it develops, it does not disappear regardless
Biotechnology cancer Clinical Trials Immunotherapies Boost immune cells’ ability to kill cancer using “Backpacks”? By Staff Reports 5 months ago Macrophages are immune cells that patrol the body looking for potential threats like viruses, bacteria,
Biotechnology Clinical Trials Coronavirus drug development rare diseases Clinical trial in COVID-19 patients tests anti-inflammatory drug developed 25 years ago at Scripps Research By Staff Reports 5 months ago An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as
Biotechnology cancer Cell Therapy Clinical Trials MD Anderson and Ipsen advance new therapy with potential benefit for underserved patients with lung and ovarian cancers By Staff Reports 5 months ago In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1),
Biotech Company News Biotechnology Coronavirus rare diseases Q BioMed Initiates Rapid Development of Novel COVID-19 Therapeutics By Staff Reports 5 months ago Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, today announced that together with
Biotechnology BGI Group helping over 80 countries for timely COVID-19 detection and intervention By Staff Reports 5 months ago Global genomics developer, BGI Group has produced more than 10 million of its Real-Time SARS-CoV-2 tests,
Biotechnology cancer Immunotherapies Immunotherapy effective in metastatic prostate cancers with specific markers of immune activation By Staff Reports 6 months ago Although metastatic castration-resistant prostate cancer (mCRPC) typically has limited response to immunotherapy, a subset of
Biotechnology Coronavirus Pharmaceuticals Prodrug rare diseases FDA clears emergency use of malaria drug, Chloroquine to treat COVID-19 By Staff Reports 6 months ago The Food and Drug Administration has authorized the emergency use of two malaria drugs seen
Biotechnology Coronavirus Researchers explore potential of highly sensitive point-of-care tests for novel coronavirus detection By Staff Reports 6 months ago As testing for the coronavirus continues throughout the United States, researchers have been closely watching
Biotechnology cancer Cell Therapy Clinical Trials Vaccines Experiments in Mice And Human Cells Shed Light On Best Way to Deliver Nanoparticle Therapy For Cancer By Staff Reports 6 months ago Researchers in the cancer nanomedicine community debate whether use of tiny structures, called nanoparticles, can
Biotechnology Coronavirus Infectious Diseases Prescriptions Research & Discovery Vaccines Patients with More Severe Forms of Coronavirus Disease Could Offer Clues to Treatment By Staff Reports 6 months ago Hundreds of clinicians worldwide are banding together in an effort to study some types of severe cases
Biotechnology Clinical Trials Coronavirus Infection Control Infectious Diseases UC San Diego Partners with 5 Leading Diagnostics Manufacturers to Boost COVID-19 Testing By Staff Reports 6 months ago Partnering with five leading in vitro diagnostics manufacturers, an interdisciplinary team of scientists and physicians
Biotechnology cancer Coronavirus Immunotherapies COVID-19 recommendations for patients receiving anti-cancer immunotherapies By Staff Reports 6 months ago We should all be doing our best to keep from catching COVID-19, if not for
Biotechnology Clinical Trials Coronavirus drug development Pharmaceuticals rare diseases FDA-approved drugs could help fight COVID-19 By Staff Reports 6 months ago Drugs that are already approved by the U.S. Food and Drug Administration (FDA) could hold
Biotech Company News Biotechnology Clinical Trials Infectious Diseases rare diseases Aqualung Therapeutics Advances Its Investigational Monoclonal Antibody into Ind-Enabling Studies of Acute Respiratory Distress Syndrome (ARDS) And Ventilator-Induced Lung Injury (VILI) By Staff Reports 7 months ago Aqualung Therapeutics Corporation is developing ALT-100, a therapeutic monoclonal antibody, to combat serious unchecked inflammation.
Biotech Company News Biotechnology Immunotherapies rare diseases Biotech Launches Development of Immunotherapy to Treat COVID-19 Coronavirus Infection By Staff Reports 7 months ago Cancer immunotherapy developer, CEL-SCI Corporation is working on an immunotherapy with the potential to treat the COVID-19
Biotechnology Coronavirus Radiology May Help in Detecting COVID-19 in Patients Affected By Staff Reports 7 months ago While COVID-19, previously known as the novel coronavirus, was first reported in China, it was
Biotechnology Clinical Trials drug development Combination of engineered cold sore virus and inhibitor drugs could destroy brain tumors By Staff Reports 7 months ago Researchers who discovered that an engineered cold sore virus could help destroy brain tumors from
Biotechnology cancer rare diseases Radiation therapy for patients with colon cancer works better with discovery of specific protein blocking By Staff Reports 7 months ago Researchers at Washington University School of Medicine in St. Louis appear to have discovered a